Association of triglyceride-glucose index and stroke recurrence among nondiabetic patients with acute ischemic stroke

被引:37
作者
Yang, Xiaomeng [1 ,2 ]
Wang, Guangyao [3 ]
Jing, Jing [1 ,2 ]
Wang, Anxin [1 ,2 ]
Zhang, Xiaoli [1 ,2 ]
Jia, Qian [1 ,2 ]
Meng, Xia [1 ,2 ]
Zhao, Xingquan [1 ,2 ]
Liu, Liping [1 ,2 ]
Li, Hao [1 ,2 ]
Wang, Yongjun [1 ,2 ,4 ]
Wang, Yilong [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, 119,South 4th Ring West Rd, Beijing 100070, Peoples R China
[2] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[3] Beijing Jishuitan Hosp, Dept Neurol, Beijing, Peoples R China
[4] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Insulin resistance; Ischemic stroke; Prognosis; Triglyceride-glucose index; stroke recurrence; death; HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; INSULIN-RESISTANCE; PREVALENCE; CHINA; RISK; SENSITIVITY; PERSISTENCE; INFARCTION; PROGNOSIS;
D O I
10.1186/s12883-022-02588-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Backgroud and purpose Triglyceride-glucose (TyG) index has been considered a surrogate marker of insulin resistance. We investigated the association between TyG index and stroke recurrence and compared the effectiveness of TyG index with homeostasis model assessment of insulin resistance (HOMA-IR) in predicting stroke recurrence and death in nondiabetic acute ischemic stroke patients. Methods Nondiabetic acute ischemic stroke patients from the ACROSS-China (Abnormal Glucose Regulation in Patients with Acute Stroke across China) registry were included. TyG index was performed and classified into four groups by quartiles. The outcomes were stroke recurrence and death within 1 year. The association between TyG index and the risk of stroke recurrence and death were analyzed by Cox regression models. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the prediction of TyG index and HOMA-IR for stroke recurrence and death. Delong test was used for comparing the differences between area under the curve (AUC) of TyG index and HOMA-IR. Results Among the 1226 patients included, the median (interquartile range) of TyG index was 5.8 (5.5-6.2). Both the third and fourth quartiles of TyG index were associated with an increased risk of stroke recurrence (adjusted hazard ratio 2.04, 95% confidence interval 1.26-3.31; adjusted hazard ratio 1.86, 95% confidence interval 1.13-3.06). Patients with fourth quartiles of TyG index were associated with a higher mortality risk (adjusted hazard ratio, 2.91; 95% confidence interval, 1.62-2.53). Regarding stroke recurrence within 1 year, the AUC (95% confidence interval) of the ROC curve for the TyG index was similar to that of the HOMA-IR[0.56 (0.52-0.61) vs 0.57 (0.52-0.61); P = 0.93]. Regarding death within 1 year, the AUCs (95% confidence interval) of the ROC curve for the TyG index and HOMA-IR were 0.55 (0.50-0.61) and 0.59 (0.53-0.64), respectively (P = 0.32). Conclusions Elevated TyG index was associated with an increased risk of stroke recurrence and death. However, neither of TyG nor HOMA-IR can be a qualified predictor of stroke recurrence and death in nondiabetic acute ischemic stroke patients.
引用
收藏
页数:9
相关论文
共 40 条
[1]   Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers [J].
Abbasi, F ;
McLaughlin, T ;
Lamendola, C ;
Yeni-Komshian, H ;
Tanaka, A ;
Wang, T ;
Nakajima, K ;
Reaven, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :3903-3906
[2]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[3]   In vivo 2H2O administration reveals impaired triglyceride storage in adipose tissue of insulin-resistant humans [J].
Allister, Candice A. ;
Liu, Li-fen ;
Lamendola, Cindy A. ;
Craig, Colleen M. ;
Cushman, Samuel W. ;
Hellerstein, Marc K. ;
McLaughlin, Tracey L. .
JOURNAL OF LIPID RESEARCH, 2015, 56 (02) :435-439
[4]  
[Anonymous], 1989, STROKE, V20, P1407
[5]   Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[6]   Secondary preventive medication persistence and adherence 1 year after stroke [J].
Bushnell, C. D. ;
Olson, D. M. ;
Zhao, X. ;
Pan, W. ;
Zimmer, L. O. ;
Goldstein, L. B. ;
Alberts, M. J. ;
Fagan, S. C. ;
Fonarow, G. C. ;
Johnston, S. C. ;
Kidwell, C. ;
LaBresh, K. A. ;
Ovbiagele, B. ;
Schwamm, L. ;
Peterson, E. D. .
NEUROLOGY, 2011, 77 (12) :1182-1190
[7]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[8]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[9]   Age Differences in Clinical Characteristics, Health care, and Outcomes after Ischemic Stroke in China [J].
Deng, Ya-Xian ;
Wang, Yi-Long ;
Gao, Bao-Qin ;
Wang, Chun-Xue ;
Zhao, Xing-Quan ;
Liu, Li-Ping ;
Wang, An-Xin ;
Zhou, Yong ;
Liu, Gai-Fen ;
Du, Wan-Liang ;
Zhang, Ning ;
Jing, Jing ;
Meng, Xia ;
Xu, Jie ;
Wang, Lin-Yu ;
Wang, Yong-Jun .
CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (10) :819-826
[10]   Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents [J].
Di Pino, Antonino ;
DeFronzo, Ralph A. .
ENDOCRINE REVIEWS, 2019, 40 (06) :1447-1467